Noradrenaline
Chronic Liver Failure
University of California, Los AngelesSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 89/ 100
Competitive context
4 Active assets in the Chronic Liver Failure cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Angiotensin Ii University of California, Los Angeles | Phase 4 | BB |
Serostim Post Graduate Institute of Medical Education and Research, Chandigarh | Phase 2/3 | B |
Ribavirin Gilead Sciences | Phase 2 | B |
Sofosbuvir Gilead Sciences | Phase 2 | B |
rtx001 Resolution Therapeutics Limited | Phase 1/2 | CCC |
View all 10 →
Same molecule, other indications
Noradrenaline is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →